Diagnostic performance of standard breast MR imaging compared to dedicated axillary MR imaging in the evaluation of axillary lymph node

Background Breast magnetic resonance (MR) imaging does not usually assess axillary lymph nodes -using dedicated axillary sequence. The additional utility of dedicated axillary sequence is poorly understood. We evaluated the diagnostic performance of dedicated axillary imaging sequence for evaluation of axillary lymph node. Methods In this retrospective study from January 2018 to March 2018, 750 consecutive women underwent breast MR imaging. 263 patients were excluded, due to neoadjuvant chemotherapy ( n  = 235), incomplete histopathological information ( n  = 14) and follow-up loss (n = 14), 487 women were included. Two radiologists scored lymph node on confidence level scale from 0 (definitely benign) to 4 (definitely malignant), −using standard MR and dedicated axillary imaging sequences. Diagnostic performance parameters were compared and calculated correlation coefficient of quantitative features (largest dimension, cortical thickness, and the ratio of cortical thickness to largest dimension of lymph node). Results 68 (14.0%) were node-positive and 419 (86.0%) were node-negative. The sensitivity, specificity, positive, negative predictive values and accuracy were respectively, 66.2, 93.3, 61.6, 94.4, and 89.5% for dedicated axillary sequence and 64.7, 94.0, 63.8, 94.3, 89.9% for standard MR sequence The dedicated axillary and standard sequences s did not exhibit significant differences in detection of positive lymph nodes (AUC, 0.794 for standard and 0.798 for dedicated axillary sequence, P  = 0.825). The cortical thickness appeared to be the most discriminative quantitative measurement using both axillary (AUC, 0.846) and standard sequences (AUC, 0.823), with high correlation coefficient (0.947). Conclusion Evaluation of axillary nodal status using standard breast MR imaging is comparable to dedicated axillary MR imaging.

[1]  I. Narabayashi,et al.  Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. , 2007, European journal of radiology.

[2]  R. Beets-Tan,et al.  The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review , 2015, Insights into Imaging.

[3]  Pre-operative MRI exhibits limited utility in axillary staging for breast cancer , 2017 .

[4]  C. Boetes,et al.  Breast MRI: guidelines from the European Society of Breast Imaging , 2008, European Radiology.

[5]  Ralf-Dieter Hilgers,et al.  Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  C. Catalano,et al.  Effect of Preoperative Breast Magnetic Resonance Imaging on Surgical Decision Making and Cancer Recurrence Rates , 2012, Investigative radiology.

[7]  T. Uematsu,et al.  In vitro high-resolution helical CT of small axillary lymph nodes in patients with breast cancer: correlation of CT and histology. , 2001, AJR. American journal of roentgenology.

[8]  J. Wildberger,et al.  Noninvasive Nodal Staging in Patients With Breast Cancer Using Gadofosveset-Enhanced Magnetic Resonance Imaging: A Feasibility Study , 2013, Investigative radiology.

[9]  Jiani Hu,et al.  The Value of T2* in Differentiating Metastatic from Benign Axillary Lymph Nodes in Patients with Breast Cancer - A Preliminary In Vivo Study , 2014, PLoS ONE.

[10]  C. Reynolds,et al.  Preoperative axillary imaging with percutaneous lymph node biopsy is valuable in the contemporary management of patients with breast cancer. , 2013, Surgery.

[11]  T. Coşkun,et al.  Contribution of kinetic characteristics of axillary lymph nodes to the diagnosis in breast magnetic resonance imaging. , 2012, Balkan medical journal.

[12]  Yulei Jiang,et al.  Accuracy of axillary lymph node staging in breast cancer patients: an observer-performance study comparison of MRI and ultrasound. , 2013, Academic radiology.

[13]  Sang-Woo Lee,et al.  The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and 18F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer , 2013, Journal of breast cancer.

[14]  W. Kaiser,et al.  Application of MR mammography beyond local staging: is there a potential to accurately assess axillary lymph nodes? evaluation of an extended protocol in an initial prospective study. , 2011, AJR. American journal of roentgenology.

[15]  C. Xie,et al.  A new, preoperative, MRI-based scoring system for diagnosing malignant axillary lymph nodes in women evaluated for breast cancer. , 2012, European journal of radiology.

[16]  H Mumtaz,et al.  Staging of symptomatic primary breast cancer with MR imaging. , 1997, AJR. American journal of roentgenology.

[17]  Guo‐Jun Zhang,et al.  Predicting axillary lymph node metastases in breast cancer patients with tumors under 2 cm in size , 1999, Breast cancer.

[18]  C. Redmond,et al.  Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update , 1983, Cancer.

[19]  F. Fornasa,et al.  Diffusion‐weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer , 2012, Journal of magnetic resonance imaging : JMRI.

[20]  J. Youk,et al.  Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer , 2014, Acta radiologica.

[21]  F. Gilbert,et al.  Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes. , 2002, The British journal of radiology.

[22]  S. Hochwald,et al.  Magnetic resonance imaging for axillary staging in patients with breast cancer , 2009, Journal of magnetic resonance imaging : JMRI.

[23]  B. Kang,et al.  Diagnostic value of breast MRI for predicting metastatic axillary lymph nodes in breast cancer patients: diffusion-weighted MRI and conventional MRI. , 2014, Magnetic resonance imaging.

[24]  R. Fábregas,et al.  Complete Axillary Lymph Node Dissection Versus Clinical Follow-up in Breast Cancer Patients with Sentinel Node Micrometastasis: Final Results from the Multicenter Clinical Trial AATRM 048/13/2000 , 2012, Annals of Surgical Oncology.

[25]  Qifeng Yang,et al.  Evaluation of axillary lymph node status in breast cancer with MRI , 1999, Breast cancer.

[26]  S. Lundgren,et al.  Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI , 2000, European Radiology.

[27]  Hiroshi Honda,et al.  Detection of axillary node metastasis using diffusion-weighted MRI in breast cancer. , 2013, Clinical imaging.

[28]  A. Luini,et al.  Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. , 2013, The Lancet. Oncology.

[29]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[30]  A. Luciani,et al.  Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results. , 2004, AJR. American journal of roentgenology.

[31]  L. Tafra,et al.  Positive Ultrasound-guided Lymph Node Needle Biopsy in Breast Cancer may not Mandate Axillary Lymph Node Dissection , 2017, Annals of Surgical Oncology.

[32]  L. Jacks,et al.  Accuracy of unenhanced MR imaging in the detection of axillary lymph node metastasis: study of reproducibility and reliability. , 2012, Radiology.